The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISHL12 2022 | Challenges and questions surrounding the use of liquid biopsy in lymphoma
In this video, Sven Borchmann, MD, University of Cologne, Cologne, Germany, discusses the importance of liquid biopsy as a diagnostic tool that may assist targeted therapy, and the challenges with using liquid biopsy assays in patients with lymphoma. Dr Borchmann also comments on the ongoing debate about whether these assays should be commercialized, and how to best implement these in clinical practice. This interview took place at the 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Ownership interest in and am founder of Liqomics
